Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,455 signal articles · 146 in last 24h · 154,143 total before filter · latest 1h ago
146last 24h
875last 7d
147● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings108M&A125Regulatory21Product21Analyst17
✕ clear all filtersticker: BKNGsentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is Booking Holdings (BKNG) a Buying Opportunity as AI Fears Weigh on the Stock?
Insider Monkey49d agobullish
Is Booking Holdings (BKNG) a Buying Opportunity as AI Fears Weigh on the Stock?

Antipodes Partners published its “Antipodes Global Strategy” second-quarter 2026 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook. A copy of the letter can be downloaded here. The second quarter of 2026 delivered one of the strongest equity market recoveries in recent history, as global equities gained 14.9% in US dollar terms. Renewed […]

Strong Earnings Push the S&P 500 to New Record High
Barchart50d agobullish
Strong Earnings Push the S&P 500 to New Record High

The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. September E-mini S&P futures (ESU26 ) are up +0.50%, and September E-mini Nasdaq futures...

Booking (NASDAQ:BKNG) Beats Q2 CY2026 Sales Expectations
StockStory51d agobullish
Booking (NASDAQ:BKNG) Beats Q2 CY2026 Sales Expectations

Online travel agency Booking Holdings (NASDAQ:BKNG) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 8.1% year on year to $7.35 billion. Its non-GAAP profit of $2.54 per share was 4.5% above analysts’ consensus estimates.

Bloomberg51d agobullish
Eli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally

(Bloomberg) -- Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed for a split.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevApple’s New CEO Taps Retired Hardware Executive for Management TeamTaco Bell Met With Michigan on Parasite Weeks Before RecallMamdani Dismisses Business Leaders Advising NYC’s Mayor’s FundS&P 5

3 Market-Beating Stocks to Target This Week
StockStory55d agobullish
3 Market-Beating Stocks to Target This Week

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.

Jim Cramer on Booking Holdings: “I Think It’s a Buy”
Insider Monkey77d agobullish
Jim Cramer on Booking Holdings: “I Think It’s a Buy”

Booking Holdings Inc. (NASDAQ:BKNG) was among Jim Cramer’s stock calls on Mad Money, as he highlighted the AI opportunities in neoclouds. Noting that it went through a stock split, a caller asked for Cramer’s thoughts on the stock. He replied: Okay, now remember, this stock’s last quarter, Glenn Fogel’s a terrific CEO, this stock’s last […]